1. Home
  2. Uncategorized
  3. Global Market Analysis Of Continuous Glucose Monitoring Device Market By Component, By End User, And By Region (Global Market Forecast To 2027)

Global Market Analysis Of Continuous Glucose Monitoring Device Market By Component, By End User, And By Region (Global Market Forecast To 2027)

Publication Month: Jun 2020 | No. of Pages: 126 Published By: Reports Intellect
Single User License: US $ 3500
Corporate User License: US $ 6500

Market Definition

The Global Continuous Glucose Monitoring Device market is estimated at $ 3.95 billion in 2019, and expected to reach $ 10.50 billion by 2027, with a CAGR of 13% from 2020 to 2027.

Continuous Glucose Monitoring Device is a medical device that is use to monitor the blood glucose level continuously throughout the day and night. An individual can analyze the blood glucose level any time at a glance.

Market Dynamics

The Global Continuous Glucose Monitoring Device market is primarily driven by factors such as the growing occurrences of diabetes; growing demand of continuous glucose monitoring devices; growing geriatric population; technological innovation; growing numbers of novel & advanced diabetes care devices; changing lifestyle and unhealthy eating habits; are some of the market dynamics.

Market Segmentation

The Global Continuous Glucose Monitoring Device Market is mainly classified based on Component, End User, and Region.

  • Based on Component, the market is further segmented into Sensors, Receivers, Integrated Insulin Pumps, Transmitters
  • Based on End User, the market is further segmented into Hospitals, Homecare Settings, and Other Users

Regional Analysis

Based on geography, the Global Continuous Glucose Monitoring Device market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided into the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is categorized into China, Japan, India, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa

Reports Intellect Analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Competitive Landscape

Global Continuous Glucose Monitoring Device Market, competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Global Continuous Glucose Monitoring Device sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2019-2027, this study provides the Global Continuous Glucose Monitoring Device sales, revenue and market share for each player covered in this report.

The major players covered in Global Continuous Glucose Monitoring Device are Animas Corporation, Abbott Laboratories, Roche Diagnostics, Dexcom Inc., Medtronic Inc., GlySens Inc., Novo Nordisk, Ypsomed AG, Menarini Diagnostics, Echo Therapeutics Inc., Senseonics Holdings Inc., and other prominent players.

Continuous Glucose Monitoring Device Market Key Segments:

By Component

  • Sensors
  • Receivers
  • Integrated Insulin Pumps
  • Transmitters

By End User

  • Hospitals
  • Homecare Settings
  • Other Users

By Region

  • North America
  • The U.S.A
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Italy
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • Japan
  • South Korea
  • Rest of Asia Pacific
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • GCC Countries
  • Egypt
  • South Africa
  • Rest of Middle East & Africa

Table of Content

1 Market Overview

1.1 Continuous Glucose Monitoring Device Introduction

1.2 Market Analysis by Component

1.2.1 Overview: Global Continuous Glucose Monitoring Device Revenue by Component: 2019 VS 2021 VS 2027

1.2.2 Sensors

1.2.3 Receivers

1.2.4 Integrated Insulin Pumps

1.2.5 Transmitters

1.3 Market Analysis by End User

1.3.1 Overview: Global Continuous Glucose Monitoring Device Revenue by End User: 2019 VS 2021 VS 2027

1.3.2 Hospitals

1.3.3 Homecare Settings

1.3.4 Other Users

1.4 Overview of Global Continuous Glucose Monitoring Device Market

1.4.1 Global Continuous Glucose Monitoring Device Market Status and Outlook (2019-2027)

1.4.2 North America (United States, Canada and Mexico)

1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)

1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.5 South America, Middle East & Africa

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Medtronic Plc

2.1.1 Medtronic Plc Details

2.1.2 Medtronic Plc Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Medtronic Plc SWOT Analysis

2.1.4 Medtronic Plc Product and Services

2.1.5 Medtronic Plc Continuous Glucose Monitoring Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.2 Animas Corporation

2.2.1 Animas Corporation Details

2.2.2 Animas Corporation Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Animas Corporation SWOT Analysis

2.2.4 Animas Corporation Product and Services

2.2.5 Animas Corporation Continuous Glucose Monitoring Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.3 Abbott Laboratories

2.3.1 Abbott Laboratories Details

2.3.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Abbott Laboratories SWOT Analysis

2.3.4 Abbott Laboratories Product and Services

2.3.5 Abbott Laboratories Continuous Glucose Monitoring Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.4 Roche Diagnostics

2.4.1 Roche Diagnostics Details

2.4.2 Roche Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Roche Diagnostics SWOT Analysis

2.4.4 Roche Diagnostics Product and Services

2.4.5 Roche Diagnostics Continuous Glucose Monitoring Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.5 Dexcom Inc.

2.5.1 Dexcom Inc. Details

2.5.2 Dexcom Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 Dexcom Inc. SWOT Analysis

2.5.4 Dexcom Inc. on Product and Services

2.5.5 Dexcom Inc. Continuous Glucose Monitoring Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.6 GlySens Inc.

2.6.1 GlySens Inc. Details

2.6.2 GlySens Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 GlySens Inc. SWOT Analysis

2.6.4 GlySens Inc. Product and Services

2.6.5 GlySens Inc. Continuous Glucose Monitoring Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.7 Novo Nordisk

2.7.1 Novo Nordisk Details

2.7.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Novo Nordisk SWOT Analysis

2.7.4 Novo Nordisk Product and Services

2.7.5 Novo Nordisk Continuous Glucose Monitoring Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.8 Ypsomed AG

2.8.1 Ypsomed AG Details

2.8.2 Ypsomed AG Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 Ypsomed AG SWOT Analysis

2.8.4 Ypsomed AG Product and Services

2.8.5 Ypsomed AG Continuous Glucose Monitoring Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.9 Menarini Diagnostics

2.9.1 Menarini Diagnostics Details

2.9.2 Menarini Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 Menarini Diagnostics SWOT Analysis

2.9.4 Menarini Diagnostics Product & Services

2.9.5 Menarini Diagnostics Continuous Glucose Monitoring Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2020) 2.10 Echo Therapeutics Inc.

2.10.1 Echo Therapeutics Inc. Details

2.10.2 Echo Therapeutics Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 Echo Therapeutics Inc. SWOT Analysis

2.10.4 Echo Therapeutics Inc. Product & Services

2.10.5 Echo Therapeutics Inc. Continuous Glucose Monitoring Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2020) 2.11 Other Players

3 Sales, Revenue and Market Share by Manufacturer

3.1 Global Continuous Glucose Monitoring Device Sales and Market Share by Manufacturer (2019-2020)

3.2 Global Continuous Glucose Monitoring Device Revenue and Market Share by Manufacturer (2019-2020)

3.3 Market Concentration Rate

3.3.1 Top 3 Continuous Glucose Monitoring Device Manufacturer Market Share in 2019 & 2020

3.3.2 Top 6 Continuous Glucose Monitoring Device Manufacturer Market Share in 2019 & 2020

3.4 Market Competition Trend

4 Global Market Analysis by Regions

4.1 Global Continuous Glucose Monitoring Device Sales, Revenue and Market Share by Regions

4.1.1 Global Continuous Glucose Monitoring Device Sales and Market Share by Regions (2019-2020)

4.1.2 Global Continuous Glucose Monitoring Device Revenue and Market Share by Regions (2019-2020)

4.2 North America Continuous Glucose Monitoring Device Sales and Growth Rate (2019-2020)

4.3 Europe Continuous Glucose Monitoring Device Sales and Growth Rate (2019-2020)

4.4 Asia-Pacific Continuous Glucose Monitoring Device Sales and Growth Rate (2019-2020)

4.5 South America Continuous Glucose Monitoring Device Sales and Growth Rate (2019-2020)

4.6 Middle East and Africa Continuous Glucose Monitoring Device Sales and Growth Rate (2019-2020)

5 North America by Country

5.1 North America Continuous Glucose Monitoring Device Sales, Revenue and Market Share by Country

5.1.1 North America Continuous Glucose Monitoring Device Sales and Market Share by Country (2019-2020)

5.1.2 North America Continuous Glucose Monitoring Device Revenue and Market Share by Country (2019-2020)

5.2 United States Continuous Glucose Monitoring Device Sales and Growth Rate (2019-2020)

5.3 Canada Continuous Glucose Monitoring Device Sales and Growth Rate (2019-2020)

5.4 Mexico Continuous Glucose Monitoring Device Sales and Growth Rate (2019-2020)

6 Europe by Country

6.1 Europe Continuous Glucose Monitoring Device Sales, Revenue and Market Share by Country

6.1.1 Europe Continuous Glucose Monitoring Device Sales and Market Share by Country (2019-2020)

6.1.2 Europe Continuous Glucose Monitoring Device Revenue and Market Share by Country (2019-2020)

6.2 Germany Continuous Glucose Monitoring Device Sales and Growth Rate (2019-2020)

6.3 UK Continuous Glucose Monitoring Device Sales and Growth Rate (2019-2020)

6.4 France Continuous Glucose Monitoring Device Sales and Growth Rate (2019-2020)

6.5 Russia Continuous Glucose Monitoring Device Sales and Growth Rate (2019-2020)

6.6 Italy Continuous Glucose Monitoring Device Sales and Growth Rate (2019-2020)

7 Asia-Pacific by Regions

7.1 Asia-Pacific Continuous Glucose Monitoring Device Sales, Revenue and Market Share by Regions

7.1.1 Asia-Pacific Continuous Glucose Monitoring Device Sales and Market Share by Regions (2019-2020)

7.1.2 Asia-Pacific Continuous Glucose Monitoring Device Revenue and Market Share by Regions (2019-2020)

7.2 China Continuous Glucose Monitoring Device Sales and Growth Rate (2019-2020)

7.3 Japan Continuous Glucose Monitoring Device Sales and Growth Rate (2019-2020)

7.4 Korea Continuous Glucose Monitoring Device Sales and Growth Rate (2019-2020)

7.5 India Continuous Glucose Monitoring Device Sales and Growth Rate (2019-2020)

7.6 Southeast Asia Continuous Glucose Monitoring Device Sales and Growth Rate (2019-2020)

7.7 Australia Continuous Glucose Monitoring Device Sales and Growth Rate (2019-2020)

8 South America by Country

8.1 South America Continuous Glucose Monitoring Device Sales, Revenue and Market Share by Country

8.1.1 South America Continuous Glucose Monitoring Device Sales and Market Share by Country (2019-2020)

8.1.2 South America Continuous Glucose Monitoring Device Revenue and Market Share by Country (2019-2020)

8.2 Brazil Continuous Glucose Monitoring Device Sales and Growth Rate (2019-2020)

8.3 Argentina Continuous Glucose Monitoring Device Sales and Growth Rate (2019-2020)

9 Middle East & Africa by Countries

9.1 Middle East & Africa Continuous Glucose Monitoring Device Sales, Revenue and Market Share by Country

9.1.1 Middle East & Africa Continuous Glucose Monitoring Device Sales and Market Share by Country (2019-2020)

9.1.2 Middle East & Africa Continuous Glucose Monitoring Device Revenue and Market Share by Country (2019-2020)

9.2 Saudi Arabia Continuous Glucose Monitoring Device Sales and Growth Rate (2019-2020)

9.3 Turkey Continuous Glucose Monitoring Device Sales and Growth Rate (2019-2020)

9.4 Egypt Continuous Glucose Monitoring Device Sales and Growth Rate (2019-2020)

9.5 South Africa Continuous Glucose Monitoring Device Sales and Growth Rate (2019-2020)

10 Global Continuous Glucose Monitoring Device Market Segment by Component

10.1 Global Continuous Glucose Monitoring Device Sales Market Share by Component (2019-2020)

10.2 Global Continuous Glucose Monitoring Device Revenue Market Share by Component (2019-2020)

10.3 Global Continuous Glucose Monitoring Device Price by Component (2019-2020)

11 Global Continuous Glucose Monitoring Device Market Segment by End User

11.1 Global Continuous Glucose Monitoring Device Sales Market Share by End User (2019-2020)

11.2 Global Continuous Glucose Monitoring Device Revenue Market Share by End User (2019-2020)

11.3 Global Continuous Glucose Monitoring Device Price by End User (2019-2020)

12 Market Forecast

12.1 Global Continuous Glucose Monitoring Device Sales, Revenue and Growth Rate (2021-2027)

12.2 Continuous Glucose Monitoring Device Market Forecast by Regions (2021-2027)

12.2.1 North America Continuous Glucose Monitoring Device Market Forecast (2021-2027)

12.2.2 Europe Continuous Glucose Monitoring Device Market Forecast (2021-2027)

12.2.3 Asia-Pacific Continuous Glucose Monitoring Device Market Forecast (2021-2027)

12.2.4 South America Continuous Glucose Monitoring Device Market Forecast (2021-2027)

12.2.5 Middle East & Africa Continuous Glucose Monitoring Device Market Forecast (2021-2027)

12.3 Continuous Glucose Monitoring Device Market Forecast by Component (2021-2027)

12.3.1 Global Continuous Glucose Monitoring Device Sales Forecast by Component (2021-2027)

12.3.2 Global Continuous Glucose Monitoring Device Market Share Forecast by Component (2021-2027)

12.4 Continuous Glucose Monitoring Device Market Forecast by End User (2021-2027)

12.4.1 Global Continuous Glucose Monitoring Device Sales Forecast by End User (2021-2027)

12.4.2 Global Continuous Glucose Monitoring Device Market Share Forecast by End User (2021-2027)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

15.3 Disclaimer

15.4 About Us

Reason to Buy

  • Current and future of Uncategorized Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Uncategorized Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Uncategorized Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Uncategorized Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets